Navigation Links
ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical
Date:8/31/2011

IRVINGTON, N.Y., Aug. 31, 2011 /PRNewswire/ -- ORTHOCON, Inc., a privately-held therapeutic device company, today announced the signing of an exclusive, worldwide license agreement with Bezwada Biomedical to develop and commercialize Bezwada's technology for bone applications.  

Bezwada Biomedical is an innovation-driven company with proprietary technology platforms comprised of bioabsorbable and biocompatible polyurethanes and polyamides derived from hydrolyzable isocyanates. This technology can be utilized to create absorbable surgical devices for a variety of applications including structural support, fixation, and drug delivery, with the potential to address significant limitations of existing therapeutic modalities.

John J. Pacifico, President and Chief Executive Officer of ORTHOCON, commented, "This strategic partnership is another important milestone for ORTHOCON as it significantly enhances the company's technological capabilities and product pipeline." He added, "Bezwada Biomedical has invented new technology that clearly improves upon existing marketed products, and we are very pleased to be working with Dr. Bezwada and his team to develop and commercialize additional devices that address the needs of our surgeon customers."

"We are delighted to partner with ORTHOCON to develop and commercialize an important part of our technology for bone applications," stated Rao Bezwada, Ph.D., President and Chief Executive Officer of Bezwada Biomedical. "Given ORTHOCON's financial, technical, and commercial capabilities, we believe this is the right step to move our technology forward and we are thrilled to be working with the ORTHOCON team."

Richard Kronenthal, Ph.D., ORTHOCON's Founder, Chief Scientific Officer, and principal technology inventor, previously worked with Dr. Bezwada to develop several market-leading products. Commenting on this strategic partnership, Dr. Kronenthal stated, "Having known and worked with Dr. Bezwada for many years, and having assessed the advantages of his materials relative to other marketed technologies, I am enthusiastic about the new roads we are taking together to overcome important problems in orthopedic and other surgical specialties."  

ORTHOCON recently initiated development programs to advance the Bezwada technology towards commercialization.  

About Bezwada Biomedical

Bezwada Biomedical, established in 2003, is focused on novel and biocompatible materials applicable to unmet medical and surgical needs. The company, with specialized laboratory and manufacturing facilities in Hyderabad, India and Hillsborough, New Jersey, develops and produces novel polymers and precursors at experimental and commercial scales. For more information, please visit www.bezwadabiomedical.com.

About ORTHOCON

Founded in 2005, ORTHOCON develops, manufactures, markets, and sells products that stop bone bleeding. In 2011, ORTHOCON announced the commercial introduction of its first 510(k) cleared product, Hemasorb Absorbable Bone Hemostat Matrix, and the 510(k) clearance of Hemasorb Apply, a proprietary applicator designed to deliver Hemasorb and other ORTHOCON products presently under development.  

ORTHOCON is funded by leading international venture capital investment firms. The company occupies 8,000 square feet at its state-of-the-art facility in Irvington, New York. For more information, please visit www.orthocon.com .


'/>"/>
SOURCE ORTHOCON, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ORTHOCON®, Inc. Receives 510(k) Clearance to Market HEMASORB Apply™
2. ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®
3. ORTHOCON® Announces U.S. Market Launch of HEMASORB®
4. Caliper Life Sciences Announces IVIS Spectrum CT
5. Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011
6. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
7. Elbit Imaging Announces Availability of Investor Relations Presentation - Analysis Sources and Uses
8. Elbit Imaging Ltd. Announces Second Quarter Results for 2011
9. Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011
10. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
11. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 24, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the Cowen and Company ... Boston Marriott Copley Place on Tuesday, March 7, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
(Date:2/24/2017)... 24, 2017 Research and Markets has announced the ... 2016" report to their offering. ... The latest research Dry eye Drugs Price Analysis and Strategies ... eye market. The research answers the following questions: ... their clinical attributes? How are they positioned in the Global Dry eye ...
(Date:2/24/2017)... , Feb. 24, 2017 Medical information ... to increase their self-service capabilities to manage inquiries ... (HCPs). New research from consulting leader ... have developed self-service website portals where HCPs can ... just one of many findings to emerge from ...
Breaking Medicine Technology:
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... rehabilitation and alcohol treatment programs in British Columbia, Canada, at https://www.sunshinecoasthealthcentre.ca/ , ... its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment to innovation ...
(Date:2/26/2017)... ... February 26, 2017 , ... Today, ... the 7th Edition of International Social Design Awards. , The 7th A' ... System Designers, Governments and Institutions worldwide with realized projects and conceptual works. , ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... and reporting for healthcare organizations. This comprehensive and customizable solution empowers StaffBridge ... StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects critical reporting data, ...
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... 2017 , ... Dr. Ronald E. Hawkins, vice president for ... Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as the new dean of ... Bell comes to Liberty from the Ohio University Heritage College of Osteopathic Medicine ...
Breaking Medicine News(10 mins):